Fatty acid synthase and liver triglyceride metabolism: housekeeper or messenger?
- PMID: 22009142
- PMCID: PMC3288544
- DOI: 10.1016/j.bbalip.2011.09.017
Fatty acid synthase and liver triglyceride metabolism: housekeeper or messenger?
Abstract
Fatty acid synthase (FAS) catalyzes the de novo synthesis of fatty acids. In the liver, FAS has long been categorized as a housekeeping protein, producing fat for storage of energy when nutrients are present in excess. Most previous studies of FAS regulation have focused on the control of gene expression. However, recent findings suggest that hepatic FAS may also be involved in signaling processes that include activation of peroxisome proliferator-activated receptor α (PPARα). Moreover, reports of rapid alterations in FAS activity as well as findings of post-translational modifications of the FAS protein support the notion that dynamic events in addition to transcription impact FAS regulation. These results indicate that FAS enzyme activity can impact liver physiology through signaling as well as energy storage and that its regulation may be complex. This article is part of a Special Issue entitled Triglyceride Metabolism and Disease.
Copyright © 2011 Elsevier B.V. All rights reserved.
Figures


Similar articles
-
Nutrient-dependent phosphorylation channels lipid synthesis to regulate PPARα.J Lipid Res. 2013 Jul;54(7):1848-59. doi: 10.1194/jlr.M036103. Epub 2013 Apr 13. J Lipid Res. 2013. PMID: 23585690 Free PMC article.
-
Hepatic PGC-1beta overexpression induces combined hyperlipidemia and modulates the response to PPARalpha activation.Arterioscler Thromb Vasc Biol. 2007 Dec;27(12):2707-13. doi: 10.1161/ATVBAHA.107.155739. Epub 2007 Oct 11. Arterioscler Thromb Vasc Biol. 2007. PMID: 17932310
-
Farnesol decreases serum triglycerides in rats: identification of mechanisms including up-regulation of PPARalpha and down-regulation of fatty acid synthase in hepatocytes.Lipids. 2008 Jul;43(7):619-27. doi: 10.1007/s11745-008-3192-3. Epub 2008 May 29. Lipids. 2008. PMID: 18509688
-
Regulation of energy metabolism by long-chain fatty acids.Prog Lipid Res. 2014 Jan;53:124-44. doi: 10.1016/j.plipres.2013.12.001. Epub 2013 Dec 18. Prog Lipid Res. 2014. PMID: 24362249 Review.
-
Regulation of fatty acid synthase gene expression: an approach for reducing fat accumulation.J Anim Sci. 1993 Jul;71(7):1957-65. doi: 10.2527/1993.7171957x. J Anim Sci. 1993. PMID: 8349524 Review.
Cited by
-
Coffee pulp improves glucose and lipid metabolism disorder in high-fat diet-induced diabetic mice.Metabol Open. 2024 Jul 31;23:100303. doi: 10.1016/j.metop.2024.100303. eCollection 2024 Sep. Metabol Open. 2024. PMID: 39188638 Free PMC article.
-
Low fat diet versus low carbohydrate diet for management of non-alcohol fatty liver disease: A systematic review.Front Nutr. 2022 Aug 16;9:987921. doi: 10.3389/fnut.2022.987921. eCollection 2022. Front Nutr. 2022. PMID: 36051903 Free PMC article.
-
MiR-205 Mediated Cu-Induced Lipid Accumulation in Yellow Catfish Pelteobagrus fulvidraco.Int J Mol Sci. 2018 Sep 29;19(10):2980. doi: 10.3390/ijms19102980. Int J Mol Sci. 2018. PMID: 30274304 Free PMC article.
-
Hepatic Proteomic Changes and Sirt1/AMPK Signaling Activation by Oxymatrine Treatment in Rats With Non-alcoholic Steatosis.Front Pharmacol. 2020 Mar 10;11:216. doi: 10.3389/fphar.2020.00216. eCollection 2020. Front Pharmacol. 2020. PMID: 32210812 Free PMC article.
-
Proprotein convertase subtilisin kexin type 9 promotes intestinal overproduction of triglyceride-rich apolipoprotein B lipoproteins through both low-density lipoprotein receptor-dependent and -independent mechanisms.Circulation. 2014 Jul 29;130(5):431-41. doi: 10.1161/CIRCULATIONAHA.113.006720. Epub 2014 May 23. Circulation. 2014. PMID: 25070550 Free PMC article.
References
-
- Wu M, Singh SB, Wang J, Chung CC, Salituro G, Karanam BV, Lee SH, Powles M, Ellsworth KP, Lassman ME, Miller C, Myers RW, Tota MR, Zhang BB, Li C. Antidiabetic and antisteatotic effects of the selective fatty acid synthase (FAS) inhibitor platensimycin in mouse models of diabetes. Proc Natl Acad Sci U S A. 2011;108:5378–5383. - PMC - PubMed
-
- Grundy SM, Brewer HB, Jr, Cleeman JI, Smith SC, Jr, Lenfant C. Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation. 2004;109:433–438. - PubMed
-
- Marchesini G, Brizi M, Bianchi G, Tomassetti S, Bugianesi E, Lenzi M, McCullough AJ, Natale S, Forlani G, Melchionda N. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes. 2001;50:1844–1850. - PubMed
-
- Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA. 2002;287:356–359. - PubMed
-
- Austin MA, Hokanson JE, Edwards KL. Hypertriglyceridemia as a cardiovascular risk factor. Am J Cardiol. 1998;81:7B–12B. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous